The role of RANKL and FGF23 in Assessing Bone Turnover in Type 2 Diabetic Patients.

NiÈa, G; NiÈa, O; Gherasim, A; Arhire, L I; Herghelegiu, A M; Mihalache, L; Tuchilus, C; Graur, M

NiÈa, G; NiÈa, O; Gherasim, A; Arhire, L I; Herghelegiu, A M; Mihalache, L; Tuchilus, C; Graur, M.

Afiliação

NiÈa G; "Grigore T Popa" University of Medicine and Pharmacy, Faculty of Medicine, Iasi.
NiÈa O; "Grigore T Popa" University of Medicine and Pharmacy, Faculty of Medicine, Iasi.
Gherasim A; "Grigore T Popa" University of Medicine and Pharmacy, Faculty of Medicine, Iasi.
Arhire LI; "Grigore T Popa" University of Medicine and Pharmacy, Faculty of Medicine, Iasi.
Herghelegiu AM; "Carol Davila" University of Medicine and Pharmacy, Faculty of Medicine, Bucharest, Romania.
Mihalache L; "Grigore T Popa" University of Medicine and Pharmacy, Faculty of Medicine, Iasi.
Tuchilus C; "Grigore T Popa" University of Medicine and Pharmacy, Faculty of Medicine, Iasi.
Graur M; "Grigore T Popa" University of Medicine and Pharmacy, Faculty of Medicine, Iasi.

Acta Endocrinol (Buchar) ; 17(1): 51-59, 2021.

Article em En | MEDLINE | ID: mdl-34539910

Palavras-chave

FGF23; RANKL; bone turnover; type 2 diabetes

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Acta Endocrinol (Buchar) Ano de publicação: 2021 Tipo de documento: Article País de publicação: Romênia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google